Novartis Sandoz Unit Gets FDA Approval for Multiple Sclerosis Biosimilar By Molly McKee August 27, 2023
Novartis Collaborates With Six Organizations to Expand Clinical Trial Diversity By Molly McKee July 26, 2023
